The Pattern of Fasting and Post 75 G Glucose Loading of Glucagon-Like Peptide 1 Levels in Obese and Non-Obese Subjects
BACKGROUND: Prevalence of obesity increased sharply recently; it was associated with an increased prevalence of several cardiometabolic diseases. Reduced glucagon-like peptide 1 (GLP-1) secretion is observed among obese subjects in many studies, and it may mediate the failure of insulin secretion response to food intake.
AIM: To evaluate the pattern of fasting and post 75 g glucose loading of GLP-1 levels in obese and non-obese subjects.
METHODS: An experimental study on the pattern of GLP-1 levels in fasting state and response in post 75 g glucose loading in obese and non-obese subjects, was conducted. Sixteen obese and 16 non-obese subjects were enrolled in the study, with age- and sex-matching in both groups. GLP-1 levels were measured at fasting state (0), 15, 30, 60, and 120 minutes post-glucose loading.
RESULTS: The GLP-1 response to glucose loading were similar in obese and non-obese subjects, which increased from fasting state to post glucose loading and reaching the peak levels in 15 minutes, then declined until the end of observation. There was tendency that GLP-1 levels in fasting state and post glucose loading were lower in obese subjects compared to in non-obese subjects (in fasting state, 5.67 vs. 6.16 ng/mL, P = 0.338; in 15 minutes, 6.20 vs. 6.94 ng/mL, P = 0.239; in 30 minutes 6.20 vs. 6.90 ng/mL, P = 0.264; in 60 minutes, 5.77 vs. 6.12 ng/mL, P = 0.242), but the difference were not statistically significant, except in 120 minutes (5.24 vs. 6.67 ng/mL, P = 0.049; in obese and non-obese subjects, respectively). Similar finding was also seen in the pattern of response (delta) of GLP-1 from time-to-time observation among obese and non-obese subjects (0-15 minutes [0.52 vs. 0.8 ng/mL, P = 0.350], 0-30 minutes [0.53 vs. 0.74, P = 0.550], 0-60 minutes [0.11 vs. 0.31 ng/mL, P = 0.546], in 0-120 minute [-0.42 vs. 0.31, P = 0.006]).
CONCLUSIONS: The patterns of GLP-1 levels post glucose loading were similar in obese and non-obese subjects which increased from fasting state to post glucose loading, reaching the peak levels in 15 minutes and then declined until the end of observation, except in non-obese subjects where the GLP-1 levels were increased at 120 minutes. There was a tendency of GLP-1 levels in fasting state and post-glucose loading to be lower in obese subjects compared within non-obese subjects.
Plum Analytics Artifact Widget Block
WHO. Global Health Observatory (GHO) data [serial online], 2017. URL: http://www.who.int/gho/ncd/risk_factors/obesity_text/en/. Accessed in July 15, 2017.
WHO. Metabolic Syndrome data [serial online], 2014. URL: http://www.who.int/mediacentre/factsheet/fs211/en/. Accessed in June 29, 2017.
Basic Health Research (Riset Kesehatan Dasar). Badan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia, Tahun, 2007.
Basic Health Research (Riset Kesehatan Dasar). Badan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia, Tahun, 2013.
Suastika K, Dwipayana P, Saraswati MR, Gotera W, Budhiarta AAG, Sutanegara IND, Gunadi IGN, Nadha KB, Wita W, Rina K, Santoso A, Matsumoto K, Kajiwara N, Taniguchi H. Metabolic syndrome and diabetes in Bali. JAFES. 2011; 26:159-162. https://doi.org/10.15605/jafes.026.02.14
Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V. Attenuated GLP1 secretion in obesity: cause or consequence? Gut. 1996; 38:916-919. https://doi.org/10.1136/gut.38.6.916 PMid:8984033 PMCid:PMC1383202
Faerch K, Torekov S, Vistisen D, Johansen NB, Witte DR, Jonsson A, Pedersen O, Hansen T, Lauritzen T, Sandbaek A, Holst JJ, Jorgensen ME. GLP1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: THE ADDITION-PRO Study. Diabetes. 2015; 64:2513-25. https://doi.org/10.2337/db14-1751 PMid:25677912
Munoz JSG, Rodriguez DJ, Morante JJH. Diurnal rhytms of plasma GLP1 levels in normal and overweight/obese subjects: lack of effect of weight loss. J Physiol Biochem. 2015; 71:17-28. https://doi.org/10.1007/s13105-014-0375-7 PMid:25543251
Holst JJ. The Physiology of glucagon-like peptide-1. Physiol Rev. 2007; 87:1409-1439. https://doi.org/10.1152/physrev.00034.2006 PMid:17928588
Lastya A, Saraswati MR, Suastika K. The low level of glucagon-like peptide-1(GLP1) is a risk factor of type 2 diabetes mellitus. BMC Research Notes. 2014; 7:849. https://doi.org/10.1186/1756-0500-7-849 PMid:25427660 PMCid:PMC4417523
Manell H, Staaf J, Manukyan L, Kristinsson H, Cen J, Stenlid R, Ciba I, Forslund A, Bergsten P. Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2016; 21:1-9. https://doi.org/10.1210/jc.2015-3885
Adam TCM, Westerperp MSP. Glucagon-like peptide release and satiety after a nutrient challenge in normal-weight and obese subjects. Br J Nutri. 2005; 93:845-851. https://doi.org/10.1079/BJN20041335
Yeow TP, Pacini G, Tura A, Hor CP, Lim SL, Tan FHS, Tong CV, Hong JYH, Zain FM, Holst JJ, Mohamud WNW. Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus. Br Med J Open Diabetes Res Care. 2017; 5:e000352. https://doi.org/10.1136/bmjdrc-2016-000352 PMid:28321312 PMCid:PMC5353273
Yamane S, Harada N, Hamasaki A, Muraoka A, Joo E, Suzuki K, Nasteska D, Tanaka D, Ogura M, Harashima S, Inagaki N. Effects of glucose and mealmingestion on incretin secretion in Japanese subjects with norma glucose tolerance. J Diabetes Invest. 2012; 3:80-85. https://doi.org/10.1111/j.2040-1124.2011.00143.x PMid:24843549 PMCid:PMC4014936
Kozawa J, Okita K, Imagawa A, Iwahashi H, Holst JJ, Yamagata K, Shimomura I. Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes. Biochem Biophysic Res Communicat. 2010; 393:410-413. https://doi.org/10.1016/j.bbrc.2010.01.134 PMid:20138827
Copyright (c) 2019 Ida Bagus Aditya Nugraha, Made Ratna Saraswati, Ketut Suastika
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.